CLARiFY: Neurodevelopment in Type 1 Diabetes

 

CLARiFY is a groundbreaking new grant awarded by the NIDDK (National Institute for Diabetes and Diabetic and Kidney Diseases). Dr. Eva Feldman and her Australian collaborators, including Co-PI’s, Dr. Fergus Cameron and Richard Bear, from Murdoch Children’s Institute and Monash University, will use measures taken from Type 1 diabetes patients over a 30-year timespan to uncover how the disease leads to cognitive complications.